Nutex Health (NASDAQ:NUTX) Given New $357.00 Price Target at B. Riley Financial

Nutex Health (NASDAQ:NUTX) had its price target hoisted by investment analysts at B. Riley Financial from $325.00 to $357.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley Financial‘s target price would suggest a potential upside of 91.09% from the stock’s current price.

NUTX has been the subject of a number of other research reports. Wall Street Zen lowered Nutex Health from a “buy” rating to a “hold” rating in a research note on Saturday, October 31st. LADENBURG THALM/SH SH began coverage on Nutex Health in a research note on Monday, October 26th. They set a “buy” rating and a $336.00 target price on the stock. Lake Street Capital reissued a “buy” rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Weiss Ratings upgraded Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, October 6th. Finally, Zacks Research downgraded Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Nutex Health presently has a consensus rating of “Moderate Buy” and an average target price of $334.33.

Nutex Health Price Performance

Shares of NUTX traded up $6.26 during trading hours on Monday, reaching $186.82. 17,063 shares of the stock traded hands, compared to its average volume of 166,292. The company has a market cap of $1.28 billion, a P/E ratio of 7.95 and a beta of 0.66. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The company’s 50-day moving average price is $203.11 and its two-hundred day moving average price is $151.38. Nutex Health has a 52-week low of $83.99 and a 52-week high of $226.16.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.54 by $0.17. The business had revenue of $217.61 million during the quarter, compared to analyst estimates of $214.82 million. Nutex Health had a return on equity of 35.99% and a net margin of 20.68%. On average, analysts anticipate that Nutex Health will post 26.65 earnings per share for the current year.

Insider Transactions at Nutex Health

In other Nutex Health news, Director Scott Saunders sold 203 shares of the business’s stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the sale, the director owned 400 shares in the company, valued at $85,700. The trade was a 33.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 44.68% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in NUTX. BlackRock Inc. purchased a new position in shares of Nutex Health in the second quarter valued at $69,612,000. Winmill & CO. Inc. bought a new stake in Nutex Health in the second quarter worth $11,168,000. Empowered Funds LLC purchased a new stake in Nutex Health during the second quarter valued at $7,720,000. Bank of New York Mellon Corp purchased a new stake in Nutex Health during the second quarter valued at $3,956,000. Finally, Bridge City Capital LLC purchased a new stake in Nutex Health during the third quarter valued at $3,918,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.